BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
68970 results:

  • 1. Gender disparity between first and senior authors on liver cancer research in the top journals of Gastroenterology and Hepatology.
    Shi H; Xu H; Huang S; Tan Z; Ma X; Zhang H; Zhang W; Shi L; Zhong X; Lü M; Chen X; Tang X
    PLoS One; 2024; 19(5):e0295648. PubMed ID: 38820519
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Geriatric End-of-Life Screening Tool Prediction of 6-Month Mortality in Older Patients.
    Haimovich AD; Burke RC; Nathanson LA; Rubins D; Taylor RA; Kross EK; Ouchi K; Shapiro NI; Schonberg MA
    JAMA Netw Open; 2024 May; 7(5):e2414213. PubMed ID: 38819823
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies.
    Golabi P; Owrangi S; Younossi ZM
    Aliment Pharmacol Ther; 2024 Jun; 59 Suppl 1():S1-S9. PubMed ID: 38813821
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and safety of targeted therapy plus immunotherapy combined with hepatic artery infusion chemotherapy (FOLFOX) for unresectable hepatocarcinoma.
    Lin ZP; Hu XL; Chen D; Huang DB; Zou XG; Zhong H; Xu SX; Chen Y; Li XQ; Zhang J
    World J Gastroenterol; 2024 May; 30(17):2321-2331. PubMed ID: 38813052
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis.
    Monsereenusorn C; Suwannaying K; Buaboonnam J; Sathitsamitphong L; Techavichit P; Pakakasama S; Chainansamit SO; Anurathapan U; Komvilaisak P; Traivaree C; Sanpakit K; Charoenkwan P; Seksarn P
    Asian Pac J Cancer Prev; 2024 May; 25(5):1831-1839. PubMed ID: 38809656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. liver cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.
    Igissin N; Orazbayev D; Telmanova Z; Kudaibergenova I; Mamatov N; Bilyalova Z; Igissinova G; Rustemova K; Turebayev D; Jexenova A; Adaibayev K; Sayakov U; Dzhumabayeva F; Muratbekova S; Sitnikova L; Syzdykov N; Shishkin I; Kozhakhmet K
    Asian Pac J Cancer Prev; 2024 May; 25(5):1763-1775. PubMed ID: 38809649
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Curcumin, Piperine and Taurine Combination Enhances the Efficacy of Transarterial Chemoembolization Therapy in patients with Intermediate Stage Hepatocellular Carcinoma: A Pilot Study.
    Abd El Rahiem R; Ibrahim SA; Effat H; El-Houseini ME; Osman RA; Abdelraouf A; Elzayat EM
    Asian Pac J Cancer Prev; 2024 May; 25(5):1589-1598. PubMed ID: 38809630
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RNA m
    Meng S; Jiangtao B; Haisong W; Mei L; Long Z; Shanfeng L
    Front Immunol; 2024; 15():1362159. PubMed ID: 38807595
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.
    Zhao Y; Chen C; Chen K; Sun Y; He N; Zhang X; Xu J; Shen A; Zhao S
    Sci Rep; 2024 May; 14(1):12163. PubMed ID: 38806553
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma.
    Yang S; Zheng L; Li L; Zhang J; Wang J; Zhao H; Chen Y; Liu X; Gan H; Chen J; Yan M; He C; Li K; Ding C; Li Y
    Clin Transl Med; 2024 Jun; 14(6):e1727. PubMed ID: 38804617
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.
    Mazur RD; Cron DC; Goldberg DS; Yeh H; Dageforde LA
    Clin Transplant; 2024 Jun; 38(6):e15365. PubMed ID: 38804605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlation between Angiotensin Inhibitor Administration and Longer Survival in Patients Who Underwent Curative Resection for Pancreatic cancer.
    Yang HY; Kang MY; Kang CM; Lee WJ; Hwang HK
    Yonsei Med J; 2024 Jun; 65(6):324-331. PubMed ID: 38804026
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Enhancing colorectal cancer prevention: a national assessment of public awareness in Egypt.
    Yehia SA; Alboraie M; Ashour R; Hassan D; Ezzat R; El-Raey F; Tag-Adeen M; Abdelaziz M; Asfour S; Abdellatef A; Abdeen N; Elsayed R; Elkhadry SW
    BMC Public Health; 2024 May; 24(1):1415. PubMed ID: 38802842
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Short‑ and long‑term outcomes after laparoscopic and open pancreatoduodenectomy for elderly patients: a propensity score‑matched study.
    Xu S; Deng X; Wang S; Yu G; Liu J; Gong W
    BMC Geriatr; 2024 May; 24(1):462. PubMed ID: 38802742
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.
    Zhao R; Zhou J; Miao Z; Xiong X; Wei W; Li S; Guo R
    Front Immunol; 2024; 15():1397827. PubMed ID: 38799453
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. GSK-126 Enhances All-Trans-Retinoic Acid (ATRA) Response in Hepatocellular Carcinoma (HCC) by Upregulating
    Liu Z; Zheng Y
    Discov Med; 2024 May; 36(184):1041-1053. PubMed ID: 38798263
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma.
    Sharma A; Chhipa AS; Verma S; Parikh P; Patel S
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23737. PubMed ID: 38798245
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effect of Intermittent vs. Continuous Energy Restriction on Visceral Fat: Protocol for The Healthy Diet and Lifestyle Study 2 (HDLS2).
    Lewis MY; Yonemori K; Ross A; Wilkens LR; Shepherd J; Cassel K; Stenger A; Rettenmeier C; Lim U; Boushey C; Le Marchand L
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794715
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.
    Pierce BG; Felbinger N; Metcalf M; Toth EA; Ofek G; Fuerst TR
    Viruses; 2024 May; 16(5):. PubMed ID: 38793684
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3449.